mobility shift assay (EMSA) were from Beyotime (Haimen, China). pRL-TK, AP-1 reporter plasmids, and a dual-luciferase reporter assay system were purchased from Promega (Madison, WI). All other chemicals were purchased from Sigma-Aldrich unless otherwise specifi ed.
Cell culture
Human monocyte-derived THP-1 cells (CTCC, Shanghai, China) were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 2 mM L -glutamine, 100 g/ml streptomycin, and 100 U/ml penicillin. The cells were incubated under a humidifi ed atmosphere of 95% O 2 and 5% CO 2 at 37°C (Thermo) to a density of 10 6 cells per ml. Monocytic THP-1 cells were stimulated with 100 nM PMA for 48 h to differentiate into adherent macrophages. When the differentiated phenotype was achieved, the PMA-containing medium was removed and replaced with complete RPMI 1640 supplemented with 10% FBS. The macrophages were cultured for another 24 h before treatment.
Human peripheral blood monocytes were isolated from the blood of healthy donors by density gradient centrifugation on Ficoll/Hypaque. Monocytes were purifi ed by adherence to plastic in RPMI 1640 supplemented with 10 % FBS and antibiotics for 2 h. Nonadherent cells were removed by several washes with warm PBS. Freshly isolated monocytes were thereafter differentiated into macrophages using macrophage colony-stimulating factor (50 ng/ml) for 6 days in RPMI 1640 medium containing 10% FBS. The investigation conforms to the principles outlined in the Declaration of Helsinki. The study protocol was approved by the ethics committee of Sun Yat-sen University.
The isolation and culture of macrophages from the mouse peritoneal cavity were carried out as reported previously ( 19 ) . Briefl y, the mice were euthanized and ice-cold PBS was injected into the peritoneal cavity of each mouse. This fl uid was carefully collected and centrifuged at 3,000 rpm. Then the supernatant was withdrawn and the cell pellet was resuspended in RPMI 1640 medium and allowed to adhere for 3 h, then was washed three times with prewarmed PBS to remove nonadherent cells. The medium was then replaced with fresh RPMI 1640 medium with 10% FBS. The adherent macrophages were used for further experiments.
Animals and procedures

ApoE
Ϫ / Ϫ mice (C57BL/6J background) were obtained from the Jackson Laboratory (Bar Harbor, ME) at 6 weeks of age. Mice were fed a high-cholesterol diet (containing 1.25% cholesterol) and dosed daily via intragastric gavage with 30 mg/kg Tan dissolved in 0.5% carboxy-methyl-cellulose sodium (CMC-Na) or administered 0.5% CMC-Na alone (vehicle control). After 12 weeks, mice were euthanized and aortas were collected and subjected to Western blotting analysis. The aortic sinus cryosections were analyzed for atherosclerotic lesion size with Oil Red O staining and immunohistochemistry staining as previously described ( 13 ) . The dosage of the drug used in the current study was evaluated according to a small pilot study by us ( 13 ) and reports by others ( 20 ) . All animal experimental procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Ethical Committee for Animal Research at Sun Yat-sen University.
Oil Red O staining
Foam cell formation was revealed by Oil Red O staining according to our previous report ( 21 ) . In brief, cells were fi xed with 4% paraformaldehyde and then stained by fi ltered 0.5% Oil Red (2) (3) (4) . On the contrary, SR-BI, ATP-binding cassette transporter A1 (ABCA1), and ABCG1 are responsible for the effl ux of macrophage cholesterol (5) (6) (7) . However, safe and effi cacious therapeutic agents that prevent cholesterol uptake and/or promote cholesterol effl ux are very limited.
Tanshinone IIA (Tan) (supplementary Fig. I ), a lipophilic pharmacologically active compound derived from the Chinese herb Salvia miltiorrhiza Bunge (Danshen), exerts multiple cardioprotective effects ( 8 ) . Tan has long been used clinically in Asian countries for the prevention and treatment of several CVDs, such as coronary heart disease, angina pectoris, and myocardial infarction (8) (9) (10) . We and others have demonstrated that Tan attenuates the initiation and progression of atherosclerosis in experimental animals ( 11, 12 ) . More recently, we have provided evidence that Tan can stabilize "vulnerable" atherosclerotic plaques in apolipoprotein E-defi cient (ApoE Ϫ / Ϫ ) mice fed a high-cholesterol diet ( 13 ) . However, the precise molecular mechanisms by which Tan attenuates and stabilizes atherosclerotic plaques remain largely unknown.
Heme oxygenase-1 (HO-1), the key enzyme in heme catabolism, has been reported to display several benefi cial effects in atherosclerosis-related CVDs (14) (15) (16) . In addition, emerging evidence suggests that HO-1 participates in the protective effects of Tan in several cell types ( 17, 18 ) . However, it remains unclear whether HO-1 is involved in the atheroprotective effect of Tan on foam cell formation. Therefore, the aim of the present study was to investigate whether Tan may suppress lipid accumulation in macrophage foam cells by activating HO-1.
MATERIALS AND METHODS
Chemicals and reagents
Tan (>98% purity assayed by HPLC) was a kind gift from Prof. Lianquan Gu (Department of Medicinal Chemistry, Sun Yat-sen University, Guangzhou, China). RPMI 1640 medium was purchased from Gibco BRL (Grand Island, NY). Fetal bovine serum (FBS), Alexa Fluor 594-conjugated anti-rabbit IgG (H+L) antibody, Lipofectamine 2000, nuclear factor-erythroid 2-related factor 2 (Nrf2) small interfering RNA (siRNA), HO-1 siRNA, and liver X receptor (LXR) siRNA were obtained from Invitrogen (Carlsbad, CA). Rabbit anti-CD36 and goat anti-SR-A polyclonal antibodies were purchased from R&D Systems (Minneapolis, MN). Rabbit anti-Nrf2, anti-c-Fos, and anti-c-Jun were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse anti-ABCA1 antibody was obtained from Abcam (Cambridge, MA). Rabbit anti-SR-BI and anti-ABCG1 antibodies were obtained from Novus Biologicals (Littleton, CO). Rabbit anti-HO-1 and antiphospho-Nrf2 (Ser40) antibodies were obtained from Epitomics (Burlingame, CA). Mouse anti-␣ -tubulin, rabbit anti-histone H1 antibody, phorbol 12-myristate 13-acetate (PMA), fl uorescent dye DiI, Oil Red O, 4 ′ ,6-diamidino-2-phenylindole (DAPI), Harris hematoxylin, actinomycin D, zinc protoporphyrin (ZnPP), and human HDL were purchased from Sigma-Aldrich (St. Louis, MO). Mouse anti-Mac3 antibody was obtained from BD Transduction Laboratories (San Jose, CA). PD98059, U0126, SB203580, SP600125, and calphostin C were from Calbiochem (La Jolla, CA 
RNA isolation and real-time PCR
Total RNA of cells was extracted using Trizol reagent (Invitrogen) and was converted into cDNA with reverse transcriptase according to the manufacturer's instructions (Takara, Dalian, China). Quantitative real-time PCR was used to measure the relative levels of gene expression. All primers used were custom synthesized by Invitrogen and well-validated. Quantifi cation of relative gene expression was calculated with the effi ciency-corrected 2 Ϫ ⌬ ⌬ CT method using the housekeeping gene, GAPDH, for RNA input standardization, and data were presented as fold change over control group.
Western blotting analysis
Western blotting was conducted as previously described in detail ( 24 ) . Nuclear protein, cytosol protein, or total cell protein was extracted using CelLytic nuclear/cytosol extraction kit (Sigma) with protease and phosphatase inhibitor according to the recommendations of the supplier. Anti-␣ -tubulin or anti-histone H1 antibodies were used for equal protein loading of cytosolic and nuclear proteins, respectively.
EMSA
EMSA was performed using the LightShift TM chemiluminescent EMSA kit (Pierce) according to our established procedure ( 21 ) . In brief, cells were washed with ice-cold PBS and then were scraped off the plates with a cell scraper. Nuclear extracts were prepared using the CelLytic nuclear extraction kit (Sigma) according to the manufacturer's instructions. Nuclear protein (2 g) was then used to assess DNA binding activity using 3 ′ biotinlabeled oligonucleotide probes containing the AP-1 consensus sequence: sense, 5 ′ -CGC TTG ATG ACT CAG CCG GAA-3 ′ ; antisense, 3 ′ -GCG AAC TAC TGA GTC GGC CTT-5 ′ (Beyotime). Each sample was electrophoresed in a 6% nondenaturing polyacrylamide gel in 0.5× Tris/Borate/EDTA buffer at 100 V for 60 min . For cold competition experiments, 100-fold molar excess unlabeled duplex oligonucleotides containing AP-1 consensus sequence were added to the nuclear extracts before incubation with the biotin-labeled oligonucleotides.
Luciferase reporter assay
In the AP-1 promoter activation assay, cells were seeded at 5 × 10 4 cells/well in 96-well plates, and cotransfected with AP-1 reporter plasmid (100 ng/well) and pRL-TK (10 ng/well) as an internal control for 12 h using Lipofectamine LTX and PLUS reagents (Invitrogen) according to the manufacturer's instructions. After transfection, cells were treated with Tan (1, 3, or 10 M) for 30 min and then stimulated with PMA (100 nM) for 48 h. The luciferase activity was measured using the Dual-Luciferase reporter assay system (Promega), according to the manufacturer's protocol. Relative luciferase activity was calculated as the ratio of firefl y luciferase activity to Renilla luciferase activity. For LXR activation studies, LXR response element (LXRE)-driven luciferase reporter vector (LXRE-tk-Luc), which was kindly provided by Dr. In-Kyu Lee (Kyungpook National University School of Medicine, Korea), and ␤ -galactosidase control vector (Promega) were used. Luciferase and ␤ -galactosidase activities were determined in cell lysates. The amount of luciferase activity was normalized for ␤ -galactosidase and reported as relative light units .
siRNA
Cells were transfected with negative control siRNA, HO-1 siRNA, Nrf2 siRNA, or LXR siRNA using Lipofectamine 2000 O, followed by counterstaining the nuclei with Harris hematoxylin. Photomicrographs were taken by phase-contrast microscopy (IX71, Olympus, Tokyo, Japan). Images were obtained from at least fi ve randomly chosen fi elds for each condition.
LDL isolation, modifi cation, and labeling
The use of human plasma in this study conforms to the principles outlined in the Declaration of Helsinki. LDL was isolated from fresh plasma of healthy subjects as previously described ( 21 ) . LDL was either oxidized with 5 M Cu 2+ for 24 h to generate oxidized low density lipoprotein (oxLDL), or labeled with the fl uorescent probe DiI and then oxidized to DiI-oxLDL followed by dialysis against PBS + 10 M EDTA. Endotoxin levels were tested using the Limulus Amebocyte Lysate assay kit (Bio Whittaker, Walkersville, MD). Preparations containing less than 0.5 EU/mg (LDL protein) of endotoxin were used for the experiments. The oxidative extent of each lot was monitored by agarose gel electrophoresis and colorimetrically by the thiobarbituric acid reactive substances assay . The protein concentration was determined using a BCA TM protein assay kit (Pierce, Rockford, IL). All lipoproteins were fi lter sterilized, stored at 4°C in the dark, and used within 3 weeks.
Cellular uptake of Dil-oxLDL
THP-1 monocytes were cultured on chamber slides (Warner Instruments) and stimulated with PMA (100 nM) for 48 h to differentiate them into adherent macrophages. THP-1-derived macrophages were incubated for 24 h with Tan (1-10 M) or the vehicle (0.1% DMSO). After incubation, the cells were washed twice with PBS (to bar physical interference of Tan) and incubated with DiI-oxLDL (10 g/ml) at 37°C for an additional 4 h. At the end of the incubation period, cells were washed, mounted on coverslips with glycerin jelly and examined by confocal microscopy (LSM 710, Carl Zeiss, Germany). Data were analyzed with Image-Pro Plus 6.0 software. The DiI-oxLDL uptake was determined and expressed as fold of the control.
Cholesterol contents measurement
Lipids in the thoraco-abdominal aortas of the mice and in macrophages were extracted by hexane/isopropanol [3/2 (v/v)], the solvents were evaporated, and the tissue or cell pellet was resuspended in aqueous solution with 1% Triton X-100-water. The level of cholesterol was measured using Amplex Red cholesterol assay kit (Invitrogen) according to the manufacturer's instructions ( 22 ) . Protein concentration was determined using a bicinchoninic acid (BCA) protein assay kit. Data are normalized to cellular protein content.
Cholesterol effl ux analysis
Cholesterol effl ux analysis was performed as previously described ( 23 ) . Briefl y, THP-1-derived macrophages were labeled in 0.2% BSA, serum-free RPMI 1640 medium with 50 g/ml oxLDL (used as the carrier for free cholesterol labeling), and 1 Ci/ml [ 3 H]labeled cholesterol for 24 h. After labeling, the cells were washed twice with PBS and incubated with Tan at the indicated concentrations for another 24 h. To equilibrate cholesterol pools, cells were washed twice with PBS and incubated for 24 h in RPMI 1640 containing 0.2% BSA with no lipoproteins. Cells were washed again and switched to serum-free medium containing 0.2% BSA or purifi ed apoAI (10 g/ml) (Calbiochem, Darmstadt, Germany) or native human HDL (50 g/ml) (Sigma). After incubation for 12 h, the supernatant was collected and adherent cells were lysed with 1 mol/l NaOH. Radioactivity was quantifi ed in both the supernatant and cell lysate by scintillation counting (Beckmann LS6000SC; Beckman Coulter, Somerset, Supplemental Material can be found at: Fig. 1D , treatment with Tan decreased the protein level of SR-A (1.00 in controls vs. 0.35 ± 0.06 in Tan-treated mice, P < 0.01) and CD36 (1.00 vs. 0.58 ± 0.16, P < 0.05), and increased the protein expression of ABCA1 (1.00 vs. 2.09 ± 0.13, P < 0.01) and ABCG1 (1.00 vs. 1.67 ± 0.15, P < 0.05) in the aortas of ApoE Ϫ / Ϫ mice. These fi ndings imply that chronic treatment with Tan might affect lipid accumulation in macrophages in ApoE Ϫ / Ϫ mice through regulating the expression of scavenger receptors and cholesterol transporters.
Tan regulates the expression of scavenger receptors and cholesterol transporters in human macrophages
We next investigated the effects of Tan on the expression of scavenger receptors and cholesterol transporters in human macrophages. As indicated in supplementary Fig. II , Tan treatment dose-dependently decreased mRNA expression of SR-A, but enhanced that of ABCA1 and ABCG1, without affecting CD36 and SR-BI in THP-1 macrophages. We then examined the effects of Tan on protein expression of these receptors and transporters, and the changes in protein expression paralleled with the changes in mRNA expression ( Fig. 2A ) . Notably, treatment with Tan (1, 3, or 10 M) for 24 h signifi cantly reduced the protein expression of SR-A (10 M Tan decreased the SR-A protein level to 12.82 ± 3.36% of the control, P < 0.05). Similar results were obtained in primary human monocyte-derived macrophages ( Fig. 2B ).
Tan attenuates foam cell formation by inhibiting oxLDL uptake and promoting cholesterol effl ux in lipid-laden macrophages
Based on the fact that Tan regulates the expression of scavenger receptors and cholesterol transporters, we surmised that Tan might play a role in macrophage foam cell formation. To further explore the effect of Tan on foam cell formation, differentiated THP-1 and primary human macrophages were loaded with oxLDL (50 g/ml) for 24 h in the absence or presence of Tan. Tan signifi cantly ameliorated intracellular lipid accumulation as determined by the measurement of cellular cholesterol content and by Oil Red O staining ( Fig. 3A, B ). As the regulation of cholesterol homeostasis is a fi nely-tuned process determined by net outcome of cholesterol uptake and effl ux, we next examined the effect of Tan on cholesterol uptake and effl ux. We found that Tan treatment (1, 3, or 10 M) markedly decreased DiI-oxLDL uptake ( Fig. 3C, D ) , but signifi cantly promoted apoAI-and HDL-mediated cholesterol effl ux ( Fig. 3E, F ) . However, Tan did not affect the mRNA expression of cholesterol synthesis-related genes (supplementary Fig. III) ; implying that de novo lipid synthesis was not involved in Tan-mediated reduction of foam cell formation. Taken together, these data suggest that Tan protects against the formation of macrophage foam cells by decreasing SR-A-mediated oxLDL uptake and increasing ABCA1/G1-mediated cholesterol effl ux.
Tan inhibits AP-1 expression, DNA binding activity, and transcriptional activity
AP-1 is a crucial transcription factor that regulates SR-A expression ( 25, 26 ) . Therefore, we examined the effects of (Invitrogen) for 48 h according to the manufacturer's instructions. After transfection, the cells were incubated with Tan for another 24 h. The cells were then subjected to Western blotting analysis or cholesterol content measurement.
Immunofl uorescent staining
THP-1 monocytes were cultured on 6-well chamber slides and stimulated with PMA (100 nM) for 48 h to differentiate them into adherent macrophages, followed by exposure to oxLDL (50 g/ml) for 24 h to induce macrophage foam cells. Cells were then treated with 10 M Tan or the vehicle (0.1% DMSO) for 4 h. At the end of incubation period, cells were fi xed with cold 4% (w/v) paraformaldehyde for 30 min, washed with PBS for 5 min, and permeabilized in 0.1% (w/v) Triton X-100 at room temperature for 10 min. After being washed with PBS, the cells were incubated with primary antibody against Nrf2 at 4°C overnight followed by Alexa Fluor 594-conjugated anti-rabbit IgG (H+L) secondary antibody for 1 h at room temperature. The slides were counterstained with DAPI (5 mg/ml; Sigma) and mounted in glycerin jelly medium, then subjected to confocal microscopy (LSM 710; Carl Zeiss).
Statistical analysis
All values are expressed as means ± SEM unless otherwise specifi ed. Data were analyzed by two-tailed unpaired Student's t -test between two groups and by one-way ANOVA followed by the Bonferroni post hoc test for multiple comparisons . The analyses were performed using GraphPad Prism 5.0 software (GraphPad Software Inc., La Jolla, CA). P < 0.05 was considered statistically signifi cant.
RESULTS
Tan inhibits atherogenesis and regulates the expression of scavenger receptors and cholesterol transporters in ApoE
؊ / ؊ mice We fi rst evaluated the impact of Tan treatment on the formation of atherosclerotic plaques. Six-week-old ApoE Ϫ / Ϫ mice fed a high-cholesterol diet were randomized to receive either Tan (30 mg/kg/day) or vehicle for 12 weeks. We then analyzed the development of atherosclerotic lesions in the aortic sinus by Oil Red O staining. As shown in Fig. 1A , Tan treatment markedly diminished atherosclerotic plaque size by 46.23 ± 10.68%, compared with the vehicle control group (n = 8, P < 0.05). However, Tan did not affect the serum lipid profi le (supplementary Table I ), which agrees with previous data ( 13 ) . Accumulation of macrophage foam cells in the neointima plays a key role in the development of atherosclerosis. To further evaluate the impact of Tan on macrophage content in the atherosclerotic plaques, immunohistochemical staining of the aortic sinus was performed. Notably, compared with vehicle-treated ApoE Ϫ / Ϫ control mice, the macrophage-positive area in the atherosclerotic plaques of Tan-treated mice was markedly reduced by 61.64 ± 12.28% ( Fig. 1B ) . Furthermore, cholesterol content was lower in Tan-treated aortas than it was in vehicle-treated ApoE Ϫ / Ϫ aortas ( Fig. 1C ) . Scavenger receptors (such as SR-A and CD36) and cholesterol transporters (such as SR-BI, ABCA1, and ABCG1) play crucial roles in cholesterol metabolism ( 2, 3, 5-7 ). We therefore determined whether Tan modulates cholesterol homeostasis by altering the expression of these receptors and transporters. As indicated in G1, we determined the protein expression of LXR ␣ and RXR in the nuclei of Tan-treated THP-1 macrophages. Intriguingly, treatment with Tan did not affect the nuclear expression of LXR ␣ and RXR (supplementary Fig. IV) . Furthermore, Tan exerted no effect on LXR ␣ transactivation, as determined by LXRE-mediated luciferase activity (supplementary Fig. IV) . While, LXR ␣ knockdown by the inhibitory effects of Tan on SR-A expression are partly associated with the suppression of AP-1 activity.
Tan upregulates ABCA1/G1 expression independent of LXR ␣ activation To address whether the LXR ␣ /retinoid X receptor (RXR) is involved in Tan-induced upregulation of ABCA1/ Fig. 3 . Effect of Tan on oxLDL uptake and cholesterol effl ux in human macrophages. A, B: THP-1-derived macrophages (A) or primary human macrophages (B) were coincubated with Tan (10 M) and oxLDL (50 g/ml) for 24 h. After incubation, intracellular cholesterol was extracted and determined by the Amplex Red cholesterol assay kit or cells were fi xed and stained with Oil Red O. Cellular nuclei were stained with hematoxylin. The magnifi cation of each panel is ×400. * P < 0.05 versus vehicle-treated group; # P < 0.05 versus oxLDL-treated alone group. C, D: Tan suppresses the uptake of DiI-oxLDL by THP-1 macrophages. THP-1 macrophages were incubated with Tan (1, 3, or 10 M) or vehicle (0.1% DMSO) for 24 h. The cells were then washed twice with PBS and incubated with DiI-oxLDL (10 g/ml) at 37°C for 4 h. As a negative control, cells were incubated without DiI-oxLDL. DiI-oxLDL uptake was assessed by confocal microscopy (C) and was quantifi ed by Image-Pro Plus software (D). The experiments were repeated three times independently. Data are expressed as means ± SEM (n = 3). * P < 0.05 versus Dil-oxLDL-treated alone group. E, F: THP-1-derived macrophages were incubated with 50 g/ml oxLDL and 1 Ci/ml [ In addition, Tan-induced HO-1 upregulation was completely abolished by HO-1 siRNA (S2) transfection ( Fig.  6A ). HO-1 siRNA (S2) also attenuated the effect of Tan on the downregulation of c-Fos ( Fig. 6B ) and SR-A protein expression ( Fig. 6C ) , and upregulation of ABCA1 and ABCG1 protein expression ( Fig. 6D, E ) . To verify these fi ndings, ZnPP, a specifi c HO inhibitor, was used to inhibit HO activity (supplementary Fig. VII) . Likewise, the effect of Tan on c-Fos, SR-A, ABCA1, and ABCG1 was blocked by ZnPP. Accordingly, both ZnPP and HO-1 siRNA reversed Tan's suppressive effects on oxLDL uptake and promotion of cholesterol effl ux (data not shown). Moreover, Tan-mediated diminution of lipid accumulation was also attenuated by HO-1 siRNA or ZnPP ( Fig. 6F ) . These data indicate that HO-1 functions as an upstream regulator of cholesterol uptake and effl ux in macrophages.
Tan enhances Nrf2-mediated HO-1 expression via activating extracellular signal regulated kinases
To elucidate the upstream signaling events leading to induction of HO-1 expression in Tan-treated macrophages, different kinase inhibitors were used, including PD98059 [extracellular signal regulated kinase (ERK) inhibitor], SB203580 (p38 MAPK inhibitor), SP600125 [c-Jun-N-terminal kinase (JNK) inhibitor], and calphostin C [protein kinase C (PKC) inhibitor]. We observed that Tan-mediated upregulation of HO-1 protein expression was almost completely abolished by incubation with PD98059 ( Fig. 7A ). This effect was also confi rmed by another ERK inhibitor U0126 ( Fig.  7B ) . However, SB203580, SP600125, and calphostin C had no effect on HO-1 protein expression ( Fig. 7A ) .
To further determine whether Tan induced HO-1 expression by activating ERK, we treated THP-1 macrophages with Tan at different time points and assessed the levels of phosphorylated ERK and HO-1 in vehicle-and Tan-treated macrophages. Tan rapidly induced ERK phosphorylation at 30 min and the kinetics of ERK activation preceded the upregulation of HO-1 expression by Tan ( Fig. 7C, D ) , suggesting that ERK activation functions as an upstream event in Tan-mediated HO-1 upregulation.
We have demonstrated that Tan profoundly elicited the induction of HO-1 protein in an Nrf2-dependent manner siRNA transfection or pharmacological inhibition by GGPP failed to abrogate the effect of Tan-mediated upregulation of ABCA1/G1 expression (supplementary Fig.  IV) , implying that LXR ␣ activation was not involved in Tan-induced ABCA1/G1 upregulation.
To further explore the mechanisms by which Tan increased ABCA1/G1 mRNA levels in macrophages, actinomycin D was added to both vehicle-and Tan-treated macrophages for specifi ed periods, and the half-life of ABCA1/G1 mRNA was determined by quantitative RT-PCR. Based on the observed decay curve, we found that Tan prolonged the turnover rate of ABCG1 transcripts by approximately 3-fold (t 1/2 , 125 vs. 352 min; supplementary Fig. V) , whereas Tan did not affect the turnover rate of ABCA1 transcripts (supplementary Fig. V) . These data indicate that Tan promotes ABCG1 expression through inhibition of rapid mRNA decay.
Tan modulates cholesterol metabolism through HO-1 activation
To explore the potential role of HO-1 in Tan-mediated upregulation of ABCA1 expression and suppression of cholesterol accumulation in macrophage foam cells, fi rst, we demonstrated that treatment with Tan signifi cantly upregulated protein expression of HO-1 in a dose-dependent manner in THP-1 macrophages and human primary macrophages ( Fig. 5A, B ) . The expression of HO-1 was increased in mouse peritoneal macrophages ( Fig. 5C ) and in lesional macrophages in atherosclerotic plaques ( Fig. 5D ) from Tan-treated ApoE Ϫ / Ϫ mice compared with vehicletreated mice. As HO-1 was transcriptionally regulated by Nrf2, we next determined the effect of Tan on Nrf2 expression in the nuclei. As shown in Fig. 5E , Tan signifi cantly increased Nrf2 expression dose-dependently. Moreover, transfection of siRNA targeting Nrf2 completely abrogated the effects of Tan on HO-1 expression ( Fig. 5F ).
To further determine whether HO-1 was involved in Tanmediated inhibitory effects on foam cell formation, the basal expression of HO-1 was knocked down in THP-1 macrophages by using three independent siRNAs, marked S1, S2, and S3, respectively. We observed that S2 exhibited the best effi cacy for HO-1 knockdown (supplementary Fig. VI) . Tan treatment. As shown in Fig. 7D , Western blotting analysis of the nuclear fraction demonstrated signifi cant augmentation of Nrf2 phosphorylation and translocation after Tan treatment in a time-dependent manner. Consistent with the Western blotting analysis, immunofl uorescent analysis showed augmented Nrf2 translocation into cell nuclei upon Tan treatment ( Fig. 7E ) . We then examined the effect of ERK inhibition on Tan-induced Nrf2 activation. As shown in Fig. 7F , nuclear Nrf2 phosphorylation ( Fig. 5E, F ). Previous studies have described the phosphorylation of Nrf2 (on Ser40) by several kinases as a critical process for the nuclear translocation of Nrf2, and the subsequent transactivation of various targeted genes, such as HO-1 ( 27 ) . To further explore the mechanisms of ERKmediated increased HO-1 expression by Tan, we investigated whether ERK was involved in Tan-induced Nrf2 activation. We fi rst examined the phosphorylation and subcellular localization of Nrf2 in THP-1 macrophages after been widely investigated, the molecular mechanisms by which Tan prevents atherosclerosis remain elusive, especially because the direct target of Tan is unknown. In this study, we investigated the effi cacy and the possible molecular mechanisms of Tan involved in cholesterol metabolism of macrophage-derived foam cells. The salient fi ndings of this study are summarized as: i ) Tan markedly decreases SR-A expression and oxLDL uptake in lipidladen macrophages via inhibition of AP-1; ii ) Tan induces ABCA1 and ABCG1 expression and promotes cholesterol effl ux from macrophages in an LXR-independent fashion; and iii ) Tan regulates the expression of SR-A, ABCA1, and ABCG1 and suppresses cholesterol accumulation in human macrophage foam cells via activation of the ERK/ Nrf2/HO-1 axis. These observations shed a new light on the potential anti-atherogenic properties of Tan in addition to anti-oxidative/anti-infl ammatory effects.
In Fig. 1 , we have shown that Tan attenuates atherosclerotic plaque formation in ApoE Ϫ / Ϫ mice. This is consistent with previous studies showing that Tan can inhibit atherogenesis ( 13, 32 ) . Macrophages play a critical role in the pathogenesis of atherosclerosis. The neointimal retention and accumulation increased after treatment with Tan (10 M). Inhibition of the ERK pathway by PD98059 acutely reduced the capacity of Tan to increase nuclear Nrf2 phosphorylation and accumulation. Another ERK inhibitor, U0126, showed a similar effect (data not shown). These results demonstrate the crucial role of ERK in Nrf2-dependent activation of HO-1 and suggest that Nrf2 is a downstream effector of ERK in response to Tan treatment.
DISCUSSION
Tan, one of the most bioactive constituents isolated from Salvia miltiorrhiza Bunge, has long been clinically used in Asian countries for the prevention and treatment of CVDs (8) (9) (10) . Accumulating evidence suggests that Tan prevents the development of atherosclerosis by inhibiting LDL oxidation ( 28 ) , scavenger receptor expression ( 21 ) , matrix metalloproteinase expression and activity ( 11 ), pro-infl ammatory cytokine expression ( 29 ) , and smooth muscle cell proliferation ( 30 ) and migration ( 31 ) . Although the protective effects of Tan against atherosclerosis have vitro data in cultured mouse peritoneal macrophages (supplementary Fig. IX) . Thus, it is highly plausible that the effect of Tan on CD36 expression may be different in humans and mice. This discrepancy also reminds us that we have to be cautious with extrapolation of the mouse data to humans. Therefore, it will be of interest to examine the effect of Tan on patients with atherosclerosis in future clinical studies. Another aspect in maintaining cholesterol homeostasis and foam cell formation is cholesterol effl ux, mainly mediated by ABCA1, ABCG1, and SR-BI. In animals with deficiency in these three transporters, foam cell accumulation and atherosclerotic lesions were increased (36) (37) (38) . We observed that Tan enhanced ABCA1/G1 expression in a dose-dependent manner, without altering the expression of SR-BI in human macrophages and in the aortas of ApoE Ϫ / Ϫ mice, indicating that upregulation of ABCA1/ G1 expression by Tan is mainly responsible for the increase in cholesterol effl ux and the alleviation of foam cell formation. It has been demonstrated that the expression of ABCA1/G1 is mediated through LXR ␣ , a key nuclear receptor involved in the regulation of intracellular lipid metabolism ( 39, 40 ) . However, our results indicated that Tan-mediated upregulation of ABCA1/G1 expression was independent of classic LXR ␣ activation. Therefore, the posttranscriptional regulation might be a potential mechanism underlying the effects of Tan A critical step in foam cell formation is the recognition and uptake of oxLDL by multiple macrophage scavenger receptors. SR-A and CD36 are the principal scavenger receptors responsible for the binding and uptake of modifi ed LDL in macrophages ( 33 ) . Combined inhibition of these two receptors blocks human and murine foam cell formation in vitro ( 33 ) , and genetic deletion of either SR-A or CD36 retards lesion development in ApoE Ϫ / Ϫ mice ( 34, 35 ) . In the present study, we showed that Tan decreases the expression of SR-A and CD36 in the atherosclerotic plaques of ApoE Ϫ / Ϫ mice (supplementary Fig.   VIII ). In accordance with this result, Tan markedly decreased mRNA and protein expression of SR-A in human macrophages. Intriguingly, the expression of CD36 was not altered in human macrophages, which is inconsistent with the in vivo data in ApoE Ϫ / Ϫ mice ( Fig. 1D ) and the in ated the inhibitory effect of Tan on lipid accumulation in macrophages. These data suggest that Tan protects against foam cell formation, at least in part, through HO-1 activation. HO-1 gene promoter regions contain anti-oxidant response elements (AREs), and the Nrf2 family of transcription factors can translocate and bind to AREs in response to ARE activation signals (i.e., protein kinase pathway and redox-active components), initiating HO-1 gene transcription ( 45, 46 ) . In the present study, we revealed that Tan induces HO-1 protein expression through an Nrf2-dependent mechanism. Activation of the Nrf2/HO-1 signaling pathway is regulated by several upstream protein kinases, such as MAPK and PKC ( 45, 46 ) . The MAPK cascade, including ERK, JNK1/2, and p38 MAPK, as well as the PKC pathway, have been reported to regulate HO-1 activation by different stimuli ( 45 ) . For example, isothiocyanates mediate HO-1 gene upregulation via the ERK/JNK/Nrf2 axis ( 47 ); curcumin induces HO-1 and GCLM expression through the PKC/p38 pathway ( 48 ); and diallyl sulfi de activates the ERK and p38 MAPK pathways to stimulate HO-1 gene expression ( 49 ) . To identify which signal cascade controlled the activation of HO-1 by Tan, we examined the effects of MAPK and PKC inhibitors on Tan-mediated upregulation of HO-1 expression, and the results suggest that Tan-induced HO-1 expression is dependent on the activation of ERK, rather than JNK1/2, p38 MAPK, and PKC.
Nrf2 phosphorylation is a critical process for nuclear translocation and transcriptional activity ( 27, 50 ) . Given that Tan rapidly activated ERK, which is involved in Taninduced HO-1 expression, we hypothesized that ERK might represent an upstream effector in regulating Nrf2 phosphorylation and the subsequent transcriptional response of ARE-driven HO-1 gene expression. In the present study, we showed that Tan treatment signifi cantly enhanced the phosphorylation and nuclear translocation of Nrf2, and inhibition of ERK signaling by PD98059 or U0126 led to decreased Tan-induced Nrf2 activation. Collectively, these results suggest that Tan activates the ERK pathway, and subsequently induces Nrf2 phosphorylation and nuclear translocation, and ultimately, leads to the upregulation of HO-1 expression.
The previous studies by Sussan et al. ( 51 ) and Barajas et al. ( 52 ) have consistently shown that Nrf2 expression promotes atherosclerotic lesion formation in ApoE Ϫ / Ϫ mice, which is associated with increased expression of scavenger receptor CD36. It is therefore paradoxical that Tan activates Nrf2 and inhibits atherogenesis. Nevertheless, our results show that Tan activates Nrf2 without enhancing the expression of CD36. Thus, it seems that Tan can achieve anti-oxidant and anti-infl ammatory protection mediated by Nrf2 activation and avoid enhanced oxLDL uptake mediated by increased expression of CD36. Another potential explanation is that Tan-mediated HO-1 induction may not be entirely Nrf2-dependent. In this way, increased HO-1 expression by other pathways could have overshadowed the proatherogenic effects that could potentially be derived from Nrf2 activation.
mRNA half-life of ABCG1 was considerably extended in Tan-treated macrophages versus vehicle-treated cells, suggesting that Tan increased the steady-state expression of ABCG1. However, we did not observe signifi cant alterations in the mRNA half-life of ABCA1. Previous studies reported that ABCA1 was transcriptionally regulated via LXR-independent pathways such as upstream stimulatory factor (USF) ( 41 ), AP-2 ( 42 ), and specifi city protein 1 (Sp1) ( 43 ) . Whether these pathways contribute to the induction of the ABCA1 gene by Tan warrants further investigation. To gain further insight into the mechanism of Tan on ABCA1 expression and lipid accumulation, we next examined the effect of Tan on HO-1 expression . HO-1, which is an important cytoprotective, anti-infl ammatory, and antioxidant enzyme, has been considered as a novel therapeutic target for the treatment of atherosclerotic diseases ( 14, 15 ) . Genetic deletion of HO-1 in ApoE Ϫ / Ϫ mice exhibited accelerated atherogenesis with more extensive and complex atherosclerotic plaques. Macrophages from HO-1
mice demonstrated increased foam cell formation in response to oxLDL stimulation ( 16 ) . Conversely, overexpression of HO-1 by adenoviral vectors signifi cantly protected against atherosclerotic plaque formation in ApoE Ϫ / Ϫ mice ( 44 ) . In this study, we demonstrated that Tan profoundly induces HO-1 protein expression in human macrophages. This observation sparked our interest to investigate the potential role of HO-1 in the Tan-mediated protective effect against foam cell formation. Our results showed that both the pharmacological inhibitor (ZnPP) and gene knockdown of HO-1 (siRNA) abolished the benefi cial effects of Tan on SR-A, ABCA1, and ABCG1 expression, and on cholesterol uptake and effl ux, and fi nally, attenu- One study limitation is that the present studies were mainly performed in human macrophages in vitro. Thus, the interpretation of the present data should be cautious, and further studies using in vivo approaches are necessary to verify the present results in future experiments. Systemic HO-1 Ϫ / Ϫ ApoE Ϫ / Ϫ mice or macrophage-specifi c HO-1 Ϫ / Ϫ mice are feasible approaches to demonstrate the direct role of HO-1 in the Tan-mediated suppressive effects on foam cells in vivo. Importantly, Tan has been widely used in Asian countries to prevent and treat CVDs. Therefore, further experiments in patients with atherosclerosis are required to confi rm the anti-atherogenic effect of Tan. In summary, our study demonstrates that Tan decreases SR-A-mediated oxLDL uptake via inhibition of AP-1 and increases ABCA1/G1-mediated cholesterol effl ux via the ERK/Nrf2/HO-1 pathway, ultimately resulting in reduced cholesterol accumulation in foam cells and atherosclerotic plaques ( Fig. 8 ) . These fi ndings indicate a critical role of HO-1 in Tan In Fig. 6C and 6D, the Western blot panels of tubulin as a loading control should be identical because the protein expression of SR-A and ABCA1 was detected synchronously by using the same gel and resulting PVDF membrane. Unfortunately, a tubulin immunostaining image from another independent measurement was mistakenly shown in the original published version of The data used to perform statistical analysis and the related bar graphs were accurate and not affected, and the changes in Western blot images as mentioned above do not compromise the interpretation and conclusions of the article. 
